SecBot SecBot
SC 13D/A ·Filed Nov 6, 2026

SLDB

Solid Biosciences Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed10d 10h ago SEC0001346824-26-000255
Activist stake amendment (position change)
Actionable Insight • Neutral

RA Capital's stake was diluted by the company's share issuance, not by selling. The pre-funded warrant blocker at 9.99% means RA Capital cannot increase its voting stake above that threshold without a blocker amendment. Monitor for any future amendment that removes the blocker, which would signal intent to exercise warrants and increase exposure.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$7.02
T+0 close · Nov 6, 2026 · via day close
Latest settled
−7.69%
T+5 · $6.48
Vs SPY
−6.00%
α at T+5
Next horizon
T+20
in 21d
  1. T+0 · Nov 9 $7.02entry
  2. T+1 · 7d ago +2.14%α +2.50% · $7.17
  3. T+5 · 20h ago −7.69%α −6.00% · $6.48
  4. T+20 · in 21d Pending
  5. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

RA Capital Management filed Amendment No. 14 to its Schedule 13D for Solid Biosciences, reporting a dilution of its beneficial ownership stake from a prior level to 10.8% (12,036,126 shares including pre-funded warrants). The filing states the change is solely due to share issuance by the company, not any acquisition or disposition by RA Capital. RA Capital holds pre-funded warrants for 8,178,412 additional shares but is blocked from exercising them due to a 9.99% beneficial ownership blocker.

Key Financial Metrics

Stake
10.8%
Investor
RA Capital Management, L.P.

Key Facts

  • RA Capital Management reports beneficial ownership of 12,036,126 shares (10.8% of common stock) as of November 4, 2026
  • Stake includes 11,897,896 shares held by RA Capital Healthcare Fund, 109,661 shares by Nexus Fund, 28,569 shares by a managed account, plus pre-funded warrants for 8,178,412 shares
  • Pre-funded warrants are subject to a 9.99% beneficial ownership blocker, preventing exercise
  • Dilution is attributed to share issuance by Solid Biosciences, not RA Capital trading activity
  • No transactions in the past 60 days by the reporting persons
  • Percentage based on 111,610,531 shares outstanding as of October 30, 2026 per the company's 10-Q

Financial Impact

RA Capital's voting/economic stake diluted from prior level to 10.8% due to company share issuance; pre-funded warrant overhang of 8.18M shares remains blocked

ownership percentagedilution

Risk Factors

  • Dilution from share issuance could continue if the company raises additional capital
  • Pre-funded warrant overhang of 8.18M shares (7.3% of outstanding) could be exercised if blocker is amended, adding selling pressure or signaling activist escalation

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
95% bullish (19 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13D/A Filing (Primary)0001346824-26-000255
Document: 0001346824-26-000255-index.html0001346824-26-000255
Document: 0001346824-26-000255.txt0001346824-26-000255

Track record

14 reports on SLDB

Performance horizon

5 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +20.77% at T+20 after the Mar 19, 2026 report. 6 of 6 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 4/10 Entry $6.84 Now $6.48 −5.26% settles Dec 15
  2. Nov 6, 202610d ago SC 13D/A Neutral 3/10 Viewing Entry $7.02 Now $6.48 −7.69% settles Dec 8
  3. Nov 4, 202612d ago Press Release Neutral 4/10 Entry $6.18 Now $6.48 +4.85% settles Dec 4
  4. Aug 6, 202614w ago S-3ASR Neutral 4/10 Entry $8.39 to $10.25 Now $6.48 −22.77% ▲ +22.17% +22.57% vs SPY
  5. May 12, 202626w ago Press Release Bearish 6/10 Entry $7.38 to $7.22 Now $6.48 +12.20% ▲ +2.17% +1.56% vs SPY
  6. May 7, 202627w ago Press Release Bullish 7/10 Entry $7.07 to $6.85 Now $6.48 −8.35% ▼ −3.11% −6.25% vs SPY
  7. Apr 23, 202629w ago DEFA14A Neutral 3/10 Entry $7.92 to $6.50 Now $6.48 −18.18% ▼ −17.93% −21.96% vs SPY
  8. Apr 10, 202631w ago 8-K Neutral 2/10 Entry $8.39 to $7.68 Now $6.48 −22.77% ▼ −8.46% −16.19% vs SPY
  9. Apr 1, 202632w ago EFFECT Bearish 7/10 Entry $7.38 to $7.05 Now $6.48 +12.20% ▲ +4.47% +14.19% vs SPY
  10. Mar 19, 202634w ago Press Release Bullish 8/10 Entry $7.03 to $8.49 Now $6.48 −7.82% ▲ +20.77% +11.45% vs SPY
Showing 10 of 14

US Market Status

Market Closed · Opens in 6h 39m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 6, 2026